InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Kjell Olmarker. Officer active across 1 company, notably Stayble Therapeutics AB. In total, 1 disclosures have been published. History available since 8 April 2021. The latest transaction was disclosed on 8 April 2021 (Sale). Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration